Capricor Therapeutics ( NASDAQ: CAPR ) has announced the commencement of a proposed underwritten public offering of shares of its common stock. In addition, Capricor intends to grant the underwriters a 30-day option to purchase an additional number of shares of common stock equal.
Back to Health Page
